Aller au contenu principal
Accès ouvert déclaré 2025 article

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women

0Citations signalées, ce qui n’est pas une note de qualité
112Institutions déclarées
25Pays d’affiliation déclarés

Rattachement africain : sg, us, ca, by, se, de, gb, es, au, kr, be, nl, hk, my, jp, pl, hu, fi, it, cy, mk, pk, il, gr, co. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Breast cancer polygenic risk scores (PRS) and traditional risk models (e.g., the Gail model [Gail]) are known to contribute largely independent information, but it is unclear how the overlap varies by ancestry, age, disease type (invasive breast cancer, DCIS), and risk threshold. Methods: In a retrospective case–control study, we evaluated risk prediction performance in 180,398 women (161,849 of European ancestry; 18,549 of Asian ancestry). Odds ratios (ORs) from logistic regression models and the area under the receiver operating characteristic curve (AUC) were estimated. Results: PRS for invasive disease showed a stronger association in younger (<50 years) women (OR = 2.51, AUC = 0.622) than in women ≥ 50 years (OR = 2.06, AUC = 0.653) of European ancestry. PRS performance in Asians was lower (OR range = 1.62–1.64, AUC = 0.551–0.600). Gail performance was modest across groups and poor in younger Asian women (OR = 0.94–0.99, AUC = 0.523–0.533). Age interactions were observed for both PRS (p < 0.001) and Gail (p < 0.001) in Europeans, whereas in Asians, age interaction was observed only for Gail (invasive: p < 0.001; DCIS: p = 0.002). PRS identified more high-risk individuals than Gail in Asian populations, especially ≥50 years, while Gail identified more in Europeans. Overlap between PRS, Gail, and family history was limited at higher thresholds. Calibration analysis, comparing empirical and model-based ROC curves, showed divergence for both PRS and Gail (p < 0.001), which indicates miscalibration. In Europeans, family history and prior biopsies drove Gail discrimination. In younger Asians, age at first live birth was influential. Conclusions: PRS adds value to risk stratification beyond traditional tools, especially in younger women and Asian ancestry populations.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women
Date Crossref
03/11/2025
Éditeur
MDPI AG
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Agency for Science, Technology and ResearchNational University of SingaporeGenome Institute of SingaporeNational Institutes of HealthNational Cancer InstituteMount Sinai HospitalUniversity of TorontoLunenfeld-Tanenbaum Research InstituteN.N. Alexandrov National Cancer CentreQueen's UniversityLund UniversityGerman Cancer Research CenterHeidelberg UniversityAmerican Cancer SocietyMedizinische Hochschule HannoverUniversity of CambridgeHarvard UniversityDana-Farber Cancer InstituteUniversity of ManchesterGenomics (United Kingdom)University of UtahHuntsman Cancer InstituteComplejo Hospitalario Universitario de SantiagoInstituto de Investigación Sanitaria de SantiagoServicio Gallego de SaludIntermountain HealthcareUniversität HamburgUniversity Medical Center Hamburg-EppendorfUniversity Cancer Center HamburgQIMR Berghofer Medical Research InstituteSeoul National UniversitySeoul National University HospitalKarolinska InstitutetFox Chase Cancer CenterVIB-KU Leuven Center for Cancer BiologyKU LeuvenBrigham and Women's HospitalLeipzig University of Applied SciencesLife UniversityLeipzig UniversitySt Mary's HospitalManchester University NHS Foundation TrustSt. Mary's HospitalInstitute of Cancer ResearchBreast Cancer NowCurtin UniversityColumbia UniversityErasmus MCStockholm South General HospitalHong Kong Sanatorium and HospitalUniversity of Nottingham Malaysia CampusCancer Research MalaysiaErasmus MC Cancer InstituteDr. Margarete Fischer-Bosch-Institute of Clinical PharmacologyUniversity of TübingenAichi Cancer CenterNagoya UniversityInternational Hereditary Cancer CenterPomeranian Medical UniversityStanford UniversityUniversity of Saint MarySt. Mary's HospitalDivision of Cancer Epidemiology and GeneticsJohanniter-Krankenhaus BonnUniversity of Hong KongVlaams Instituut voor BiotechnologieUppsala UniversityThe University of MelbourneMonash HealthMonash UniversityKarolinska University HospitalNational Institute of OncologyThe Maria Sklodowska-Curie National Research Institute of OncologyManchester Academic Health Science CentreCancer Council VictoriaUniversity of Eastern FinlandKuopio University HospitalFondazione IRCCS Istituto Nazionale dei TumoriCyprus Institute of Neurology and GeneticsUniversity of MalayaBC Cancer AgencyUniversity of British ColumbiaNational Institute of Environmental Health SciencesUniversity of ChicagoMississippi State UniversityEuropean Institute of OncologyMacedonian Academy of Sciences and ArtsCancer Society of FinlandUniversity of OuluShaukat Khanum Memorial Cancer Hospital and Research CenterTechnion – Israel Institute of TechnologyUniversity of ThessalyKing's College LondonLondon CancerMayo Clinic in FloridaVanderbilt UniversityClalit Health ServicesCentre hospitalier universitaire de QuébecThe University of Western AustraliaPontificia Universidad JaverianaSubang Jaya Medical CentreNational University Health SystemSingHealthCancer Institute of New South WalesWestmead Institute for Medical ResearchPeter MacCallum Cancer CentreSingapore General HospitalChangi General HospitalTan Tock Seng HospitalSingHealth Duke-NUS Academic Medical CentreKK Women's and Children's HospitalNational Cancer Centre Singapore

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

BRCA gene mutations in cancerBreast Cancer Treatment StudiesGlobal Cancer Incidence and Screening

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.